अब आप न्यूज्ड हिंदी में पढ़ सकते हैं। यहाँ क्लिक करें
Home » IANS » Maharashtra ATS seizes narcotics valued at Rs 51 crore

Maharashtra ATS seizes narcotics valued at Rs 51 crore

Published on :

Mumbai, Sep 10 (IANS) In a major operation, the Maharashtra Anti-Terrorism Squad (ATS) seized 129 kg of banned narcotic, mephedrone or MD, worth over Rs 51 crore plus cash of more than Rs 1 crore and arrested five persons, a top official said here on Tuesday.

Deputy Commissioner of Police, ATS, Vikram Deshmane said that the gang of accused were manufacturing the drug surreptitiously at a lab in Panvel, Raigad and then distributed it in Mumbai, Thane and other places.

The accused arrested are: Abdur Razzaque Shaikh, 47, Irfan Shaikh, 43, Suleman Shaikh, 28, Naresh Maskar, 44 and Jitendra Pramath.

The operation followed a tipoff about some unknown suspects who were engaged in manufacture, transport and sale of the banned drugs, the DCP said.

The ATS laid a trap and intercepted the accused on the Eastern Express Highway.

“Initially, we recovered and seized 9 kg of MD. However, during interrogation and further investigation, we learnt about a factory which was converted as a lab for manufacturing the banned drug, Mephedrone,” Deshmane said.

Armed with the information, the ATS raided the factory and found another 120 kg drug from there and Rs 1.04 crore cash.

Deshmane said that as per available information, this could be one of the biggest narcotics networks bust and further probe is underway to nab all others involved.

Revealing the gang’s modus operandi, he said the accused manufactured the drug in powder form and later despatched it for sale in various areas in and around Mumbai area.

A raid on the lab revealed it had a sophisticated setup to manufacture the drug.

The ATS is also probing other angles, including the possible involvement of some persons with expert knowledge of pharmaceutical formulations, involved in this racket, the DCP said.



(This story has not been edited by Newsd staff and is auto-generated from a syndicated feed.)
(For more latest news and updates Like us on Facebook, Follow us on Twitter. Download our mobile app )